Press Enter to search · ESC to close

Crypto

WuXi Juwel’s CAR-T Therapy Becomes First in China’s National Basic Medical Insurance

WuXi Juwel’s CAR-T product Relma-cel (brand name: Benlysta) has entered China’s National Basic Medical Insurance catalogue, making it the first and currently only CAR-T therapy covered by the national scheme. Industry sources estimate the negotiated price at under 300,000 yuan, with patients’ out-of-pocket cost potentially below 100,000 yuan after reimbursement.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback